Ross Iain

Ross Iain is listed in filings as Director at Silence Therapeutics plc. This profile follows SEC Form 4 activity through Dec 22, 2025, including 2 public disclosures. Recent filings connect the profile to Silence Therapeutics plc (SLN). The current snapshot covers public activity from Jan 6, 2025 to Dec 22, 2025. Reported amounts are shown as $216.0K to $1.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.